Highlights from the International Symposium on Acute Leukemias (ISAL) 2017 in Munich
The importance of educating stem cell transplant recipients on tuberculosis and cytomegalovirus
Can 7+3 as induction therapy for acute myeloid leukemia (AML) be optimized?
Exploring combinatorial approaches in acute myeloid leukemia (AML) treatment
Francesco Lo Coco
Current research on coagulopathy in APL